High-intensity interval training and moderate-intensity continuous training in adults with Crohn’s disease: a pilot randomised controlled trial by Tew, Garry et al.
1 
 
This is an accepted manuscript of an article published by BMC (part of Springer Nature) in BMC 
Gastroenterology, available online at https://doi.org/10.1186/s12876-019-0936-x. It is not the copy 
of record. Copyright © 2019, The Authors. 
High-intensity interval training and moderate-intensity continuous training in adults with Crohn’s 1 
disease: a pilot randomised controlled trial 2 
 3 
Garry A. Tew,a Dean Leighton,b Roger Carpenter,c Simon Anderson,d Louise Langmead,e John 4 
Ramage,f James Faulkner,g Elizabeth Coleman,h Caroline Fairhurst,h Michael Seed,c Lindsay 5 
Bottomsi 6 
 7 
aDepartment of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle, NE1 8ST, UK. 8 
Email: garry.tew@northumbria.ac.uk   9 
bCentre for Immunobiology, Queen Mary University of London, Blizard Building, Newark Street, 10 
Whitechapel, London, E1 2AT Email: d.leighton@qmul.ac.uk  11 
cSchool of Health, Sport and Bioscience, University of East London, Stratford Campus, London, E15 12 
4LZ, UK. Email: R.Carpenter@uel.ac.uk, m.p.seed@uel.ac.uk  13 
dGuy’s and St Thomas’ NHS Foundation Trust, London, UK. Email: simon.anderson@gstt.nhs.uk   14 
eDigestive Diseases Clinical Academic Unit, Barts and the London NHS Trust, London, UK. Email: 15 
louise.langmead@bartshealth.nhs.uk   16 
fHampshire Hospitals NHS Foundation Trust, Hampshire, UK. Email: john.ramage@hhft.nhs.uk   17 
gDepartment of Sport, Exercise and Health, University of Winchester, Winchester, SO22 4NR, UK. 18 
Email: james.faulkner@winchester.ac.uk  19 
hYork Trials Unit, University of York, Heslington, York, YO10 5DD. Email: izzy.coleman@york.ac.uk, 20 
caroline.fairhurst@york.ac.uk   21 
iCentre for Psychology and Sports Science, University of Hertfordshire, Life and Medical Sciences, CP 22 
Snow Building, College Lane, Hatfield, AL10 9AB. Email: l.bottoms@herts.ac.uk   23 
 24 
Corresponding author: G.A. Tew, Associate Professor of Exercise and Health Sciences, Department of 25 
Sport, Exercise and Rehabilitation, Northumbria University, Newcastle-upon-Tyne, NE1 8ST, UK. Tel: 26 
2 
 
This is an accepted manuscript of an article published by BMC (part of Springer Nature) in BMC 
Gastroenterology, available online at https://doi.org/10.1186/s12876-019-0936-x. It is not the copy 
of record. Copyright © 2019, The Authors. 
+44 191 243 7556; Email: garry.tew@northumbria.ac.uk  27 
 28 
Abstract 29 
Background: This study assessed the feasibility and acceptability of two common types of exercise 30 
training—high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT)—31 
in adults with Crohn’s disease (CD). 32 
Methods: In this mixed-methods pilot trial, participants with quiescent or mildly-active CD were 33 
randomly assigned 1:1:1 to HIIT, MICT or usual care control, and followed up for 6 months. The HIIT 34 
and MICT groups were offered three exercise sessions per week for the first 12 weeks. Feasibility 35 
outcomes included rates of recruitment, retention, outcome completion, and exercise attendance. 36 
Data were collected on cardiorespiratory fitness (e.g., peak oxygen uptake), disease activity, fatigue, 37 
quality of life, adverse events, and intervention acceptability (via interviews). 38 
Results: Over 17 months, 53 patients were assessed for eligibility and 36 (68%) were randomised 39 
(47% male; mean age 36.9 [SD 11.2] years); 13 to HIIT, 12 to MICT, and 11 to control. The exercise 40 
session attendance rate was 62% for HIIT (288/465) and 75% for MICT (320/429), with 62% of HIIT 41 
participants (8/13) and 67% of MICT participants (8/12) completing at least 24 of 36 sessions. One 42 
participant was lost to follow-up. Outcome completion rates ranged from 89 to 97%. The mean 43 
increase in peak oxygen uptake, relative to control, was greater following HIIT than MICT (2.4 vs. 0.7 44 
mL/kg/min). There were three non-serious exercise-related adverse events, and two exercise 45 
participants experienced disease relapse during follow-up. 46 
Conclusions: The findings support the feasibility and acceptability of the exercise programmes and 47 
trial procedures. A definitive trial is warranted. Physical exercise remains a potentially useful adjunct 48 
therapy in CD. [ID: ISRCTN13021107] 49 
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Background 53 
Regular exercise training has been recommended as an adjunct therapy for people with Crohn’s 54 
disease (CD) [1-3] because of its potential beneficial effects on physical fitness, mental health, and 55 
disease-related factors such as fatigue, bone mineral loss and inflammation [4-6]. However, 56 
empirical evidence on the effects of exercise training in CD is sparse, with only a handful of 57 
intervention studies [7-11], some of which have methodological limitations, such as short follow-up, 58 
no control group, and a small sample size. Among adults with other chronic inflammatory diseases, a 59 
traditional model of exercise prescription has been moderate-intensity continuous training (MICT; 60 
e.g. 30-60 minutes of moderate-intensity continuous endurance-type exercise such as swimming, 61 
cycling or running performed 3-5 times per week) [12], but a growing body of evidence indicates 62 
that high-intensity interval training (HIIT; e.g. 0.5-4 minute bouts of vigorous exercise interspersed 63 
by periods of passive or active recovery) is a more time-efficient exercise strategy, eliciting similar or 64 
even superior cardio-metabolic adaptations compared to MICT, at least when compared on a work-65 
matched basis [13-16]. There has only been one published study investigating HIIT in CD patients to 66 
date [17], which showed that a single session of cycle-based HIIT was well tolerated and did not 67 
markedly increase pro-inflammatory cytokines (e.g., TNF-α) in a group of 15 teenagers. A greater 68 
understanding of the feasibility, acceptability and effects of different types of exercise training is 69 
needed to support the development evidence-based exercise guidelines and promotion strategies 70 
that are specific to CD. 71 
 72 
We hypothesised that supervised endurance exercise training (either as HIIT or MICT) is a safe and 73 
effective strategy for improving cardiorespiratory fitness, fatigue, quality of life and mental health in 74 
people with CD. Before embarking on a full-scale randomised controlled trial to test this hypothesis, 75 
we conducted a pilot trial to address several areas of uncertainty. For example, the possibility that 76 
many potential participants would be of working age and have disease-specific barriers to exercise 77 
(e.g., fatigue [18]) raised questions about the ability to recruit and retain individuals with CD to a 78 
4 
 
This is an accepted manuscript of an article published by BMC (part of Springer Nature) in BMC 
Gastroenterology, available online at https://doi.org/10.1186/s12876-019-0936-x. It is not the copy 
of record. Copyright © 2019, The Authors. 
clinical trial of supervised exercise training. Hence, the main aims of the Exercise for Adults with 79 
Crohn’s disease Trial (EXACT) study were to determine the acceptability and potential benefits and 80 
harms of HIIT and MICT in adults with quiescent or mildly-active CD, and the feasibility of conducting 81 
a full-scale trial.  82 
 83 
Methods 84 
Study design and setting 85 
A full description of the methods has been published [19]. The study was a multi-centre, three-arm, 86 
parallel-group, pilot randomised controlled trial. Participants were randomised 1:1:1 to receive usual 87 
care, usual care plus HIIT or usual care plus MICT. Study assessments were conducted at baseline 88 
and at 3 and 6 months after randomisation. Recruitment was from three hospital trusts in England: 89 
Guy’s and St Thomas’ NHS Foundation Trust, Barts Health NHS Trust, and Hampshire Hospitals NHS 90 
Foundation Trust. The exercise programmes were delivered in the exercise science facilities of the 91 
University of East London and the University of Winchester. Data management and statistical 92 
analysis took place at York Trials Unit, University of York. Ethics approval was granted by the Camden 93 
and Kings Cross Research Ethics Committee (reference 15/LO/1804), and all participants provided 94 
written informed consent before enrolment. The trial was registered prospectively 95 
(ISRCTN13021107). 96 
 97 
Participants 98 
We included male and female patients between 16 and 65 years of age with a clinical diagnosis of 99 
CD. Patients had to have a stool calprotectin of <250 µg/g, stable medication (>4 weeks), and 100 
quiescent or mildly-active disease, as indicated by a Crohn’s Disease Activity Index (CDAI) of <150 or 101 
150-219, respectively. Exclusion criteria were: contraindication to exercise testing or training [20], 102 
coexistent serious autoimmune disease (e.g. rheumatoid arthritis or systemic sclerosis), pregnant, 103 
planned pregnancy or major surgery within the first 3 months after randomisation, poor tolerability 104 
5 
 
This is an accepted manuscript of an article published by BMC (part of Springer Nature) in BMC 
Gastroenterology, available online at https://doi.org/10.1186/s12876-019-0936-x. It is not the copy 
of record. Copyright © 2019, The Authors. 
of venepuncture or inadequate access for venous blood sampling, and current participation in >90 105 
min/week of purposeful exercise (e.g. cycling, swimming or running) or another clinical trial. 106 
 107 
Randomisation and allocation concealment 108 
A statistician at York Trials Unit managed the randomisation process. Following baseline assessment, 109 
a research assistant emailed the statistician for notification of the participant’s group allocation. 110 
Participants were randomly assigned 1:1:1 to one of the three study groups using a computer-111 
generated randomisation schedule stratified by centre and baseline disease status (inactive [CDAI 112 
<150] or mild [CDAI 150-219]) using randomly permuted blocks of sizes 3 and 6. The block sizes and 113 
allocation sequence were not disclosed to ensure concealment.  114 
 115 
Interventions 116 
All three groups received usual care, which comprised evidence-based medical treatment 117 
optimisation. Participants allocated to usual care did not receive any supervised exercise or exercise 118 
advice as part of the trial; however, following the final study assessment they were offered a 119 
telephone-based consultation with a research assistant who discussed their individual 120 
facilitators/barriers to exercise, and provided guidance on incorporating physical activity into their 121 
lifestyle. 122 
 123 
Participants allocated to the HIIT and MICT groups were invited to complete three supervised 124 
exercise sessions per week for 12 consecutive weeks, commencing the week following their baseline 125 
assessment and randomisation. Reimbursement was provided for travel expenses. All exercise was 126 
undertaken on a leg cycle ergometer (Lode Corival or SRM Ergometer), with each session comprising 127 
a 5-minute warm-up at 15% of peak power output (Wpeak; determined during the baseline 128 
cardiopulmonary exercise test), a main conditioning phase, and then a 3-minute cool-down at 15% 129 
Wpeak. For HIIT, the conditioning phase involved ten 1-minute bouts at 90% Wpeak, interspersed 130 
6 
 
This is an accepted manuscript of an article published by BMC (part of Springer Nature) in BMC 
Gastroenterology, available online at https://doi.org/10.1186/s12876-019-0936-x. It is not the copy 
of record. Copyright © 2019, The Authors. 
with 1-minute bouts at 15% Wpeak (total session duration = 28 minutes), whereas for MICT it 131 
involved 30 minutes at 35% Wpeak (total session duration = 38 minutes). Heart rate (Polar FT1, Polar 132 
Electro, Kempele, Finland), differential ratings for central (i.e. cardiopulmonary sensations) and leg 133 
exertion (RPE-C and RPE-L, respectively; Borg CR-10 scale [21]), and general affective valence (i.e. 134 
pleasure and displeasure; 11-point feeling scale) were recorded at regular intervals during each 135 
session. The feeling scale data will be published elsewhere. Incremental cycle exercise testing to 136 
maximum volitional exertion was performed in the final sessions of weeks 4 and 8 to re-calculate 137 
Wpeak and determine if the power output of the upcoming exercise sessions needed to be changed.  138 
 139 
After the initial 12-week supervised training period, all exercise group participants were encouraged 140 
to continue a similar exercise regime in their own home or community setting without the support 141 
of the trial team.  142 
 143 
Feasibility and acceptability outcomes 144 
Trial feasibility outcomes included rates of recruitment, retention, and outcome completion. Barriers 145 
and facilitators to recruitment were also identified using a standardised questionnaire [22], which 146 
was completed by trial staff who had a responsibility for recruitment. The acceptability of the 147 
exercise programmes was assessed using group preference data (assessed before randomisation), 148 
rates of session attendance and completion, a measure of exercise enjoyment completed at 3 149 
months after randomisation (Physical Activity Enjoyment Scale, PACES [23]), and participant 150 
feedback via telephone interviews conducted after the 6-month assessments. The safety of the 151 
exercise programmes was also assessed by exploring rates of disease relapse at 3 months, the 152 
number and type of adverse events, drop-out rates, and reasons for withdrawal in each group. 153 
Relapse was defined as an increase in CDAI of ≥100 points to a score ≥150 [24]. 154 
 155 
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We pre-specified that this pilot trial would be deemed successful and lead to the development of a 156 
proposal for a full-scale trial if: (i) at least one of the exercise programmes was shown to be 157 
acceptable, based principally on participant feedback (i.e. interview data) and exercise session 158 
attendance data (acceptable attendance defined as at least 67% of participants completing at least 159 
24 of the 36 sessions); (ii) at least 24 patients being recruited within 12 months, and; (iii) complete 160 
data on cardiorespiratory fitness, CDAI, and quality of life at 3 months for at least 67% of 161 
participants. 162 
 163 
Behaviour, fitness and health outcomes  164 
The following outcome measures were assessed in all participants at baseline and 3 months after 165 
randomisation: body mass, stature, waist circumference, blood pressure, resting heart rate, 166 
cardiorespiratory fitness (ventilatory threshold and peak oxygen uptake recorded during incremental 167 
cycle ergometer testing to maximum volitional exertion), disease status (CDAI), intestinal 168 
inflammation (faecal calprotectin), and blood markers of inflammation (T lymphocyte subsets 169 
[Th1/Th2/Th17] and various cytokines including IL-6, IL-10, TNF-α and C-reactive protein; data to be 170 
published elsewhere). Standard questionnaires were also administered at baseline and 3 and 6 171 
months after randomisation, including the Inflammatory Bowel Disease Quality of Life Questionnaire 172 
(IBDQ [25]), EuroQol EQ-5D-5L (to measure health-related quality of life, [26]), IBD Fatigue Scale 173 
[27], Hospital and Anxiety Depression Scale (HADS [28]), and International Physical Activity 174 
Questionnaire-long (IPAQ [29]). (Please note that the published trial protocol contains a 175 
typographical error in that it states that the short version of the IPAQ would be administered). 176 
 177 
Sample size 178 
Following sample size guidelines for pilot studies [30], we aimed to have at least 12 participants in 179 
each group complete the study. To allow for up to 20% attrition, an overall target of 45 participants 180 
was used (15 per group). 181 
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 182 
Blinding 183 
Due to the nature of the trial, blinding of participants and intervention facilitators to group 184 
allocation was not possible. Questionnaires were completed by participants independently and 185 
checked by a researcher for completeness. Anthropometric, cardiorespiratory fitness and disease 186 
activity outcomes were assessed by researchers blinded to group allocation. Participants were asked 187 
not to disclose their allocation. 188 
 189 
Statistical analysis 190 
Data from paper case report forms were entered and checked for missing and invalid values in 191 
Microsoft Excel® then imported into Stata v15 (StataCorp) for analysis. The flow of participants 192 
through the trial is presented in a CONSORT diagram (Figure 1). Baseline data are summarised 193 
descriptively by trial arm. The guidance around analysing pilot studies states that no formal 194 
hypothesis testing should be undertaken [31], and as such quantitative outcome data are 195 
summarised using descriptive statistics only, using the principles of intention to treat. Exit interviews 196 
were analysed using qualitative content analysis [32]. 197 
 198 
Results 199 
Recruitment took place between May 2016 and September 2017, with all follow-up data collection 200 
completed by March 2018. The trial was stopped at the end of the grant funding interval, with the 201 
minimum recruitment target having been achieved. 202 
 203 
Recruitment, group allocation and participant characteristics 204 
Of 53 patients who were fully assessed for eligibility, 39 met all eligibility criteria and 36 were 205 
randomised (Figure 1). A median of 2 participants were recruited per month (range 1 to 6). The 206 
three sites recruited 19, 12 and five participants each. The most common reason for exclusion was 207 
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having active disease (n=11). Interview data (analysed for n=31; summarised in Additional File 1) 208 
revealed that most participants were recruited via face-to-face approach in clinic, with the most 209 
common reasons for enrolment being potential health benefits (n=20), altruistic motives (n=12), and 210 
it being seen as a good way to start an exercise regime (n=10). Five investigators provided feedback 211 
on barriers and facilitators to recruitment (Additional File 2). These investigators and several 212 
participants suggested that recruitment might have been easier had there been more exercise 213 
venues. An investigator from the site with the least participants (Hampshire Hospitals NHS 214 
Foundation Trust; n=5), also stated that their recruitment was hampered by there being fewer 215 
eligible patients than expected; most patients attending their clinics had active disease.  216 
 217 
<<Figure 1 here>> 218 
 219 
Thirteen participants were allocated to HIIT, 12 to MICT, and 11 to control (Figure 1). Of the 27 220 
participants who expressed a preference for a specific group before allocation, 20 (74%) preferred 221 
HIIT, 6 (22%) MICT, and one (4%) control. Interviewees recognised the need for a control group, and 222 
although control participants were generally disappointed with their allocation, they were willing to 223 
complete the study. All but one control participant reported maintaining their pre-trial exercise 224 
habits during the follow-up period, with the remaining participant explaining that they had started 225 
doing aerobic and strength training 3-4 times per week shortly after randomisation. One exercise 226 
participant said that they would have dropped out if they had been allocated to control. 227 
 228 
Table 1 shows the participant characteristics at baseline. The groups appear well balanced for the 229 
majority of variables. Seventeen participants (47%) were male and the mean age was 36.9 years (SD 230 
11.2). A higher proportion of participants were male in the HIIT (54%) and control (64%) groups than 231 
the MICT group (25%). Most participants were of white ethnicity (78%), had quiescent disease (89%), 232 
and were in paid employment (78%). The mean time since diagnosis was 13.7 years, ranging from 4 233 
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months to 38.2 years. Twenty-six participants (72%) reported having slight-to-moderate fatigue and 234 
eight (22%) reported having severe fatigue. There were very few comorbidities, which included 235 
asthma (n=3), anaemia (n=2), diabetes (n=1), ankylosing spondylitis (n=1), and bipolar disorder 236 
(n=1). The most common medication used for CD was immunosuppressants (47%) and biologics 237 
(33%). The most common previous surgery for CD was right hemicolectomy (n=11).  238 
 239 
<<Table 1 here>> 240 
 241 
Trial retention and assessment completion rates 242 
No participants formally withdrew from the study, but one HIIT participant was lost to the 6-month 243 
follow-up (Figure 1). At 3 months (i.e., intervention end-point), 34 (94%) participants completed the 244 
hospital visit, and 35 (97%) completed the university visit. At 6 months, 33 (92%) participants 245 
completed the postal questionnaire, and 32 (89%) completed the telephone interview. The 246 
interviewees stated that the logistics and content of the assessment visits were acceptable 247 
(Additional File 1).  248 
 249 
Exercise adherence, enjoyment and acceptability 250 
Of the 465 and 429 exercise sessions that were offered to HIIT and MICT participants, respectively, 251 
288 (62%) and 320 (75%) were attended, giving a combined attendance rate of 68% (608/891). All 252 
608 attended sessions were completed as planned. The mean (SD) power output used in the 253 
exercise sessions of weeks 1-4 and 9-12 were 148 (25) W and 173 (36) W respectively for the HIIT 254 
group and 50 (14) W and 54 (13) W respectively for the MICT group.  The median (range) number of 255 
sessions attended was 25 (0-36) and 25 (18-34) for the HIIT and MICT groups, respectively. Eight 256 
(62%) of the HIIT participants and eight (67%) of the MICT participants achieved the pre-specified 257 
attendance criterion of at least 24 sessions. Two HIIT participants did not attend a single exercise 258 
session: one due to illness, and the other due to work and holiday commitments. Another HIIT 259 
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participant withdrew from the intervention after completing 5 sessions due to moving abroad. The 260 
main reasons for sessions being missed were work commitments (25%, 72/286), illness (25%, 71/286 261 
[only two of which were CD-related]) and holiday (14%, 40/286) (data from both exercise groups 262 
combined).  263 
 264 
The interviews indicated mixed views about there being three sessions per week. Some participants 265 
(n=12) stated that this frequency was, or would have been (for controls), difficult to adhere to, 266 
whereas others felt this frequency to be achievable (n=11) and necessary for improving fitness (n=6). 267 
Two participants indicated that they would not have achieved this frequency had the session times 268 
not been as flexible. Three other participants stated that the frequency would have been more 269 
achievable had weekend sessions also been offered. 270 
 271 
The intensity of training completed by the HIIT participants, based on data recorded at exercise 272 
interval 9 of 10, is summarised as follows: mean (SD) RPE-C = 5.1 (1.7) (i.e. ‘hard’), RPE-L = 5.5 (1.6) 273 
(i.e. ‘hard’) and heart rate = 92% of maximum (5%). Corresponding values for the MICT participants 274 
were:  RPE-C = 2.9 (1.5) (i.e. ‘moderate’), RPE-L = 3.3 (1.5) (i.e. ‘moderate’) and heart rate 68% of 275 
maximum (6%). None of the interviewees thought that either training programme was too hard or 276 
too easy. Two participants were initially concerned that the HIIT might be too hard, but found that 277 
this did not turn out to be the case. 278 
 279 
All interviewees found cycling to be an acceptable mode of exercise, with some recognising that it 280 
could be carefully controlled and was suitable for a range of fitness levels. However, two participants 281 
said that the seat was uncomfortable. Six participants stated that they would have also liked to try 282 
other exercise modes including muscle-strengthening exercises (n=4), running (n=1), and arm-283 
cranking (n=1). Another six participants stated that they were glad running was excluded, with two 284 
participants explaining that it has previously caused them to experience bowel urgency. Feedback on 285 
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other aspects of the exercise programmes (e.g. duration, setting, provider) is summarised in 286 
Additional File 1. The mean (SD) PACES score at 3 months (i.e. intervention end-point) out of a 287 
possible 126 was 99.4 (12.9) for HIIT and 101.3 (17.4) for MICT, equating to participants reporting 288 
the exercise sessions as ‘enjoyable’.  289 
 290 
Behaviour, fitness and health measures  291 
Summary data for the behaviour, fitness and health measures are presented in Tables 2 and 3. The 292 
mean change in peak oxygen uptake from baseline to 3 months, relative to control, was greater 293 
following HIIT than MICT (+2.4 vs. +0.7 mL/kg/min). This corresponded with the mean (SD) change in 294 
peak power output from baseline to 3 months, which was +24 W (17) for HIIT, +12 W (16) for MICT, 295 
and +4 W (14) for control.  296 
 297 
<<Tables 2 and 3 here>> 298 
 299 
The interviewees reported a range of physical benefits from participating in the exercise 300 
programmes, including feeling fitter (n=8) and more energised (n=8), and having a thinner waist 301 
(n=1) and more-defined thigh muscles (n=2). Five participants also reported disease-specific 302 
benefits, such as reduced inflammation (n=1; based on routine colonoscopy findings), less frequent 303 
bowel movements (n=1), and a “calmer gut” (n=1). Mental benefits were less frequently cited, but 304 
included generally feeling better (n=2), and improvements in wellbeing (n=3) and mood (n=2). Eight 305 
participants said that the study had increased their motivation to exercise in the future, and 12 306 
participants said that they had continued exercising (a variety of regimes) since finishing the 307 
supervised sessions. 308 
 309 
Disease activity and safety 310 
Summary data for disease activity (CDAI and faecal calprotectin) are presented in Table 2.  311 
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 312 
Two participants, one from each exercise group, experienced disease relapse between baseline and 313 
3 months. The HIIT participant was a 29-year-old male. His CDAI score increased from 62 to 278 and 314 
faecal calprotectin increased from 117 to >400 µg/g. No medications were recorded at baseline or 315 
follow-up. In his exit interview, he referred to his stomach “going a bit funny but it not being a 316 
complete flare” at approximately one third of the way through the exercise programme. He thought 317 
that this “mini flare” was related to stress and not the exercise, and he was well enough to continue 318 
exercising, completing 33 sessions. Further review of his results show that a FC result done in the 6 319 
months prior to entry to the trial was >400 µg/g. At the time of entry to the trial he was on no 320 
medication having previously been on anti-TNF which was stopped due to antibody formation and 321 
clinical remission and his faecal calprotectin was being monitored. It seems likely that the in-trial 322 
flare occurred due to the progressive nature of his disease whilst on no treatment. He has since 323 
started on vedolizumab with a good response. 324 
 325 
The MICT participant was a 37-year-old female. She was stable on 15 mg/week methotrexate at 326 
baseline but and had switched to 50 mg/day azathioprine by 3 months due to troubling hair loss 327 
which she perceived as a side effect of methotrexate. Within a few weeks of that switch she was 328 
suffering symptoms of a relapse and her faecal calprotectin was raised. She also developed anaemia. 329 
Over the course of the trial her CDAI increased from 38 to 181, and faecal calprotectin from 46 to 330 
>400 µg/g. She completed 25 exercise sessions. Of the missed sessions, six were missed due to ill 331 
health (five of which due to virus/vomiting). In her exit interview, she referred to feeling tired at the 332 
end of the supervised period, and she put this down to anaemia, which she had only recently 333 
become aware of and received treatment for. It seems possible that her relapse was related to her 334 
switch in medication. She was eventually started on infliximab with a good response. 335 
 336 
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Four adverse events were also reported during the trial; all within the HIIT group. Three were rated 337 
as non-serious but exercise-related. One participant experienced a mild headache and dizziness after 338 
exercise on two separate occasions. After clinical review, these symptoms were deemed to be 339 
related to dehydration-induced migraine. The participant was re-informed about appropriate dietary 340 
and hydration habits in relation to the exercise sessions. After this, these symptoms no longer 341 
occurred. For the other adverse event, one participant vomited 5 minutes after the end of a session. 342 
This was likely due to the participant having eaten immediately before the session. The participant 343 
was re-informed about appropriate timing of meals in relation to the exercise sessions. The final 344 
adverse event was unrelated to the trial and non-serious; a participant became ill with a chest 345 
infection shortly after randomisation, resulting in them missing all of their exercise sessions. 346 
 347 
Discussion  348 
A key finding of this pilot randomised controlled trial was that the pre-specified criteria for 349 
progressing to a full-scale trial of supervised exercise training in CD were all satisfied. The minimum 350 
recruitment target was achieved, and rates of exercise attendance and outcome completion were 351 
good. Interview feedback about the exercise programmes was generally positive, with most 352 
participants stating that they enjoyed attending and experienced fitness and health benefits. There 353 
were very few exercise-related adverse events.    354 
 355 
This is the first study to test and demonstrate the feasibility and acceptability of HIIT in adults with 356 
CD. Several trials have shown HIIT to be a safe and effective exercise strategy in other clinical 357 
populations [13, 33, 34], but all previous prospective studies in CD have investigated low-to-358 
moderate-intensity exercise programmes [7-11]. The reasons for this are unclear, but may include 359 
concerns that high-intensity exercise will acutely exacerbate inflammation and CD symptoms [4]. 360 
Such concerns are not supported by the current findings or other non-trial data. Indeed, both our 361 
cycle-based HIIT and MICT programmes had good attendance figures and positive feedback, with no 362 
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participant reporting exercise causing a worsening of their symptoms. Interestingly, the majority of 363 
participants had a pre-randomisation preference for HIIT, suggesting that many patients want to 364 
exercise at a high-intensity and are not fearful of doing so (at least when under supervision and in a 365 
controlled environment). In previous work, Ploeger et al. [17] demonstrated that a single session of 366 
cycle-based HIIT was well-tolerated and did not exacerbate inflammation or disease symptoms in 15 367 
teenagers with CD. Similarly, a conference abstract reporting a prospective study of seven adults 368 
with CD participating in high-intensity continuous exercise events such as triathlons, marathons, and 369 
long-distance bike races showed no abnormal elevation of faecal calprotectin measured at 24 hours 370 
and one week after the event [35]. Five of the seven patients also had no change in their symptoms 371 
or disease activity scores. The two remaining patients showed elevated disease activity scores at 24 372 
hours after exercise, with scores returning to baseline within one week. Together, the available data 373 
appear promising regarding the safety of cycle-based HIIT; however, larger prospective studies are 374 
needed before firm recommendations can be made about the suitability of this type of training.  375 
 376 
The pre-specified criteria for planning a full-scale trial were largely met.  Sixty four percent of HIIT 377 
and MICT participants attended at least 24 of the 36 sessions (the aim was for at least 67%, this was 378 
achieved in MICT group but not in HIIT). A total of 36 participants were recruited over 17 months 379 
(mean 2.4 per month), with 27 randomised in the first 12 months. The 3-month response rate 380 
exceeded 67%. We therefore plan to progress to a full-scale trial, with some changes, that would 381 
have a main aim of determining the efficacy and safety of supervised exercise training in people with 382 
CD. The findings from our pilot work have implications for this future trial, and the proposed changes 383 
to study design are summarised in Additional File 3. The main changes relate to the intervention. 384 
Firstly, we plan to investigate one exercise programme instead of two (i.e., change to a 2-arm, 385 
exercise versus control design). Although this will remove the ability to compare different exercise 386 
programmes, it will simplify the design and make the recruitment target more attainable. Secondly, 387 
we plan to expand the exercise regime to include resistance and flexibility exercises. The addition of 388 
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resistance training, the benefits of which we are currently investigating [36], will ensure the 389 
programme aligns with global recommendations on physical activity for health [37], and promote 390 
improvements in skeletal muscle function and bone strength [38], both of which are commonly 391 
impaired in people with CD [3, 39, 40]. For the aerobic component, we plan to use a mixture of HIIT 392 
and MICT because of evidence that doing so increases the likelihood of an improvement in 393 
cardiorespiratory fitness being observed [41], and that variety can support regular attendance [42]. 394 
Offering sessions on weekends might also improve attendance rates. This was not feasible in the 395 
current study because the university facilities were unavailable at weekends. For the future trial, we 396 
are exploring whether we could deliver the intervention in community-based exercise facilities that 397 
are open 7 days per week. Potential challenges include finding an exercise venue to pair with each of 398 
the hospital sites, and ensuring appropriate staffing.   399 
 400 
Strengths of this study include blinded outcome assessment, low rates of attrition and missing data, 401 
and exercise sessions being consistently delivered as planned (when attended). The study did have 402 
some limitations, however. Firstly, the intentionally small sample size makes the study 403 
underpowered to assess efficacy, and the upper target sample size of 45 was not achieved. 404 
However, our preliminary data could be used in a meta-analysis in the future. A second limitation 405 
was the use of self-reported physical activity, which has been shown to be inaccurate when 406 
compared with objective measurement from devices such as accelerometers [43]. Thirdly, we did 407 
not use endoscopies to directly visualise the effect of exercise on the gastrointestinal tract. These 408 
two limitations can be addressed easily in the future trial by using accelerometry and capsule 409 
endoscopic evaluation, respectively. A fourth limitation was that participants were not blinded to 410 
group allocation during follow-up, making the patient-reported outcomes susceptible to bias [44]. 411 
Using a control condition that matches the exercise programme(s) for attention (e.g., flexibility or 412 
light resistance training) is a potential approach to minimising the risk of this bias. Finally, 413 
uncertainty remains about how successful recruitment and retention would be at other potential 414 
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trial sites. Given that many more sites would be required in a subsequent trial, the continued 415 
monitoring of feasibility issues through an internal pilot phase would be beneficial, particularly 416 
within the first year of recruitment.  417 
 418 
Conclusion 419 
In conclusion, cycle-based HIIT and MICT are feasible and acceptable exercise strategies in adults 420 
with quiescent or mildly-active CD. Larger-scale trials are needed to provide precise estimates of the 421 
benefits and harms of different exercise programmes, and our findings suggest that a multi-centre 422 
trial of supervised exercise training is feasible in the UK. Physical exercise remains a potentially 423 
useful adjunct therapy and lifestyle behaviour in CD.  424 
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Figure legends 592 
Figure 1. Flow of participants through the trial.  593 
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Table 1. Baseline demographics and clinical characteristics 594 
 
HIIT (n=13) MICT (n=12) Control (n=11) All (n=36) 
Age, years 37.0 (11.1) 38.5 (13.0) 35.0 (10.0) 36.9 (11.2) 
Male sex, n (%) 7 (54) 3 (25) 7 (64) 17 (47) 
White ethnicity, n (%) 10 (77) 11 (92) 7 (64) 28 (78) 
Body mass, kg 76.2 (13.5) 63.8 (12.5) 69.8 (13.2) 70.1 (13.8) 
Current smoker, n (%) 1 (8) 1 (8) 2 (18) 4 (11) 
Employment status, n (%) 
Working full- or part-time 
Student 
Other 
 
9 (69) 
1 (8) 
3 (23) 
 
10 (83) 
1 (8) 
1 (8) 
 
9 (82) 
2 (18) 
0 (0) 
 
28 (78) 
4 (11) 
4 (11) 
CD duration, years 16.1 (11.9) 11.5 (10.9) 13.7 (9.8) 13.7 (10.8) 
CD location, n (%) 
Ileum 
Colon 
Ileum and colon 
Missing 
 
4 (31) 
3 (23) 
6 (46) 
0 (0) 
 
3 (25) 
4 (33) 
4 (33) 
1 (8) 
 
4 (36) 
1 (9) 
5 (46) 
1 (9) 
 
11 (31) 
8 (22) 
15 (42) 
2 (6) 
CD activity status, n (%) 
Inactive 
Mildly active 
 
11 (85) 
2 (15) 
 
11 (92) 
1 (8) 
 
10 (91) 
1 (9) 
 
32 (89) 
4 (11) 
CDAI 74 (48) 55 (47) 73 (45) 67 (46) 
Faecal calprotectin, µg/g 89 (72) 45 (40) 56 (55) 65 (59) 
Medication for CD, n (%) 
Immunosuppressants 
Biologics 
 
8 (62) 
8 (62) 
 
5 (42) 
2 (17) 
 
4 (36) 
2 (18) 
 
17 (47) 
12 (33) 
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Oral 5-aminosalicylates   
Analgesics 
Antibiotics 
Antidiarrheals 
0 (0) 
3 (23) 
1 (8) 
1 (8) 
3 (25) 
0 (0) 
0 (0) 
1 (8) 
2 (18) 
1 (9) 
1 (9) 
1 (9) 
5 (14) 
4 (11) 
2 (6) 
3 (8) 
Previous surgery for CD, n (%) 
Defunctioning ileostomy 
Drainage of abscess 
Excision of fistula 
Right hemicolectomy 
Small bowel resection 
Left hemicolectomy 
Panproctocolectomy and 
ileostomy 
Perianal surgery 
Subtotal colectomy and 
primary anastomosis 
Other 
 
1 (8) 
1 (8) 
1 (8) 
6 (46) 
2 (15) 
0 (0) 
1 (8) 
 
1 (8) 
0 (0) 
 
2 (15) 
 
0 (0) 
1 (8) 
0 (0) 
2 (17) 
0 (0) 
0 (0) 
0 (0) 
 
0 (0) 
0 (0) 
 
0 (0) 
 
1 (9) 
0 (0) 
1 (9) 
3 (27) 
2 (18) 
1 (9) 
1 (9) 
 
1 (9) 
1 (9) 
 
3 (27) 
 
2 (6) 
2 (6) 
2 (6) 
11 (31) 
4 (11) 
1 (3) 
2 (6) 
 
2 (6) 
1 (3) 
 
5 (14) 
Data are presented as mean (SD) unless otherwise stated. 595 
  596 
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Table 2. Fitness and health measures at baseline and follow-up 597 
 HIIT MICT Control All 
Body mass, kg 
Baseline 
3 months 
 
76.2 (13.5) 
76.4 (14.4) 
 
63.8 (12.5) 
63.0 (12.7) 
 
69.8 (13.2) 
71.0 (13.5) 
 
70.1 (13.8) 
70.1 (14.3) 
Waist circumference, cm 
Baseline 
3 months 
 
87.3 (11.8) 
86.5 (9.8) 
 
79.5 (14.7) 
76.8 (12.8) 
 
83.1 (9.8) 
84.8 (8.5) 
 
83.4 (12.4) 
82.6 (11.1) 
Resting heart rate, beats/min 
Baseline 
3 months 
 
72 (8) 
72 (10) 
 
75 (12) 
74 (9) 
 
73 (11) 
 76 (10) 
 
73 (10) 
74 (10) 
Systolic blood pressure, mmHg 
Baseline  
3 months 
 
130 (12) 
126 (11) 
 
122 (17) 
120 (16) 
 
126 (13) 
128 (15) 
 
126 (14) 
125 (14) 
Diastolic blood pressure, mmHg 
Baseline 
3 months 
 
82 (10) 
78 (9) 
 
76 (9) 
74 (10) 
 
78 (8) 
79 (10) 
 
79 (9) 
77 (9) 
Ventilatory threshold, 
mL/kg/min 
Baseline 
3 months 
 
 
16.5 (4.9) 
16.8 (5.5) 
 
 
16.0 (4.1) 
18.2 (3.7) 
 
 
16.6 (6.1) 
16.1 (4.7) 
 
 
16.4 (4.9) 
17.0 (4.7) 
Peak oxygen uptake, mL/kg/min 
Baseline 
3 months 
 
27.3 (7.7) 
29.7 (8.2) 
 
28.7 (8.6) 
29.3 (6.6) 
 
28.6 (10.0) 
28.5 (9.2) 
 
28.2 (8.6) 
29.2 (7.9) 
CDAI     
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Baseline 
3 months 
74 (48) 
59 (74) 
55 (47) 
78 (48) 
73 (45) 
99 (50) 
67 (46) 
77 (59) 
Faecal calprotectin, µg/g 
Baseline 
3 months 
 
89 (72) 
100 (113) 
 
45 (40) 
63 (113) 
 
56 (55) 
69 (146) 
 
65 (59) 
77 (121) 
Data are presented as mean (SD). 598 
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Table 3. Questionnaire data at baseline and follow-up 600 
 HIIT MICT Control All 
IBDQ (32 to 224)a 
Baseline 
3 months 
6 months 
 
184 (16) 
186 (19) 
180 (20) 
 
181 (23) 
192 (18) 
189 (22) 
 
164 (17) 
174 (21) 
175 (23) 
 
177 (20) 
184 (20) 
182 (22) 
EQ-5D (-0.285 to 1)a 
Baseline 
3 months 
6 months 
 
0.85 (0.13) 
0.85 (0.10) 
0.85 (0.12) 
 
0.83 (0.12) 
0.87 (0.13) 
0.83 (0.12) 
 
0.70 (0.20) 
0.78 (0.17) 
0.77 (0.22) 
 
0.80 (0.16) 
0.83 (0.14) 
0.81 (0.16) 
IBD-F, Fatigue (0 to 20)b 
Baseline 
3 months 
6 months 
 
8.2 (3.0) 
8.3 (3.2) 
7.5 (2.5) 
 
7.8 (5.3) 
8.3 (4.9) 
7.3 (4.2) 
 
9.3 (4.1) 
7.8 (4.2) 
7.5 (4.0) 
 
8.4 (4.1) 
8.1 (4.0) 
7.4 (3.6) 
IBD-F, Activities (0 to 120)b 
Baseline 
3 months 
6 months 
 
22.3 (19.0) 
26.4 (20.5) 
27.7 (12.4) 
 
22.7 (22.5) 
25.4 (28.1) 
26.2 (20.6) 
 
34.3 (20.5) 
35.0 (20.4) 
32.4 (21.3) 
 
26.1 (20.8) 
28.7 (23.1) 
28.7 (18.4) 
HADS, Anxiety (0 to 21)b 
Baseline 
3 months 
6 months 
 
5.5 (3.9) 
5.2 (2.5) 
3.8 (3.5) 
 
6.8 (5.2) 
5.5 (3.6) 
5.3 (4.3) 
 
7.7 (4.3) 
6.2 (4.2) 
5.5 (3.6) 
 
6.6 (4.4) 
5.6 (3.4) 
4.9 (3.7) 
HADS, Depression (0 to 21)b 
Baseline 
3 months 
 
3.6 (3.1) 
2.7 (1.7) 
 
3.8 (2.9) 
2.7 (3.3) 
 
5.2 (2.9) 
2.6 (2.5) 
 
4.1 (3.0) 
2.7 (2.5) 
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6 months 2.7 (1.5) 3.1 (3.1) 4.4 (4.0) 3.4 (3.1) 
IPAQ, Total physical activity, 
MET-min/week, median (IQR) 
Baseline 
 
3 months 
 
6 months 
 
 
2874  
(1273, 6474) 
3618 
(1692, 5271) 
1188 
(99, 4149) 
 
 
3237  
(1383, 5442) 
2099  
(1441, 3729) 
2163 
(1328, 7993) 
 
 
1602  
(526, 2781) 
2928  
(2118, 5351) 
2817  
(2243, 3969) 
 
 
2484 
(1028, 4409) 
2897  
(1645, 5213) 
2557 
(1109, 4451) 
Data are presented as mean (SD) unless otherwise stated. 601 
aHigher score is better 602 
bLower score is better 603 
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Additional File 1 - Summary of telephone interview data 605 
Thirty-two (89%) participants completed a telephone exit interview. Of the four participants not 606 
interviewed, three could not be contacted, and one was not done because the participant missed all 607 
exercise and assessment sessions. A further one interview could not be analysed due to a poor 608 
quality of recording. 609 
The participants had a mixed history of exercise. Some had previously undertaken regularly 610 
structured exercise such as gym training or running, whereas others had undertaken moderate-611 
intensity physical activity as part of daily-life, e.g. walking or cycling. As per the eligibility criteria, no 612 
participants were completing >90 min/week of purposeful endurance-type exercise in the month 613 
before recruitment. No participants recalled receiving any specific advice or support regarding 614 
exercise as part of the management of their Crohn’s disease. 615 
Twenty-six participants stated their mode of recruitment. The majority (15/26, 58%) were recruited 616 
via face-to-face approach in clinic; however, others were recruited after they responded to 617 
advertisements in the Crohn’s and Colitis UK magazine and website (n=7), a poster advertisement in 618 
clinic (n=2), or a letter of invitation sent via post (n=1), suggesting that using a range of recruitment 619 
strategies is beneficial. Interviewees offered the following suggestions about why some people 620 
might not enrol on a study like this: difficulty with travelling to study sites (n=4); lack of motivation 621 
(n=3); active Crohn’s or other limiting health conditions (n=3); lack of time (n=3); not liking exercise 622 
(n=1), and; concern that exercise may do more harm than good (n=1). 623 
Participants cited various reasons for enrolling including potential health benefits (n=20), altruistic 624 
motives (n=12), and intellectual reasons (n=6; e.g. “never taken part in a study”). Some participants 625 
(n=10) also saw the study as a good way to kick-start an exercise regime.   626 
Feedback on the study procedures was mostly positive and all participants said that they would 627 
recommend the study to other people with Crohn’s disease. All respondents felt well-informed prior 628 
to enrolment, and the combination of verbal and written information was valued. One participant 629 
would have liked more information on what the exercise test involved, and another on the location 630 
and content of the exercise sessions, but otherwise participants did not have any suggestions on 631 
how the information provided at the point of recruitment could have been improved. Regarding 632 
study assessments, one participant would have preferred to give blood at the hospital rather than 633 
the university because the hospital venepuncture staff are more experienced and have access to a 634 
wider range of sampling consumables. One participant thought that the questionnaires were too 635 
long, and another thought that some of the questions were difficult to answer. The exercise test was 636 
considered hard by all participants, but relevant and worthwhile doing. 637 
The majority of participants had a pre-randomisation preference for being allocated to the HIIT 638 
group, with reasons including wanting to be challenged, and perceiving that it would be better for 639 
their fitness. The requirement for a control group was appreciated, and although control participants 640 
were disappointed with their allocation, they were happy to complete the study. Only one exercise 641 
participant said that they would have dropped out if they had been allocated to control. 642 
Participants had mixed views about there being three sessions per week. Some (n=12) stated that 643 
this frequency was, or would have been, difficult to adhere to, whereas others felt this frequency to 644 
be achievable (n=11) and necessary for improving fitness (n=6). Two participants indicated that they 645 
would not have achieved this frequency had the session times not been as flexible. Three other 646 
participants stated that the frequency would have been more achievable had weekend sessions also 647 
been offered. One participant said that they needed a day off between sessions for recovery. 648 
 649 
There was little feedback on the intensity of training; no one stated either training programme as 650 
being too hard or too easy. Two participants were initially concerned that the HIIT might be too 651 
hard, but found that this did not turn out to be the case. 652 
One person commented on the programme duration (12 weeks) initially seeming long, but that they 653 
ended up wanting to continue for longer when reaching the end. 654 
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All participants found cycling to be an acceptable mode of exercise, with some recognising that it can 655 
be carefully controlled and is suitable for a range of fitness levels. However, two participants said 656 
that the seat was a bit uncomfortable. Six participants stated that they would have liked to also try 657 
other exercise modes including muscle-strengthening exercises (n=4), running (n=1), and arm-658 
cranking (n=1). Another six participants stated that they were glad running was excluded, with two 659 
participants explaining that it has previously caused them to experience bowel urgency.   660 
Most participants did not have a preference for where the exercise was conducted. Three 661 
participants preferred it being in a university rather than a hospital, but one participant would have 662 
preferred the hospital setting. One participant appreciated the privacy that the university setting 663 
gave her, but two others would have preferred to exercise with other people. The main other point 664 
that was raised about the setting was that, for some people (n=10), it was quite far to travel to.    665 
Participants valued the exercise sessions being supervised, but no one felt that the sessions needed 666 
to medically-supervised (i.e. supervision by a non-medical exercise professional was acceptable). 667 
Two participants stated that the exercise sessions would have been boring had there not been 668 
someone there to talk to. 669 
Participants valued receiving information about their progress (i.e. changes in fitness and health 670 
measures) and reports summarising both their individual results and the overall results of the study. 671 
The interviewees reported a range of physical benefits from participating in the exercise 672 
programmes, including feeling fitter (n=8) and more energised (n=8), and having a thinner waist 673 
(n=1) and more-defined thigh muscles (n=2). Five participants also reported disease-specific 674 
benefits, such as reduced inflammation (n=1; based on routine colonoscopy findings), less frequent 675 
bowel movements (n=1), and a “calmer gut” (n=1). Mental benefits were less frequently cited, but 676 
included generally feeling better (n=2), and improvements in wellbeing (n=3) and mood (n=2). Eight 677 
participants said that the study had increased their motivation to exercise in the future, and 12 678 
participants said that they had continued exercising (a variety of regimes) since finishing the 679 
supervised sessions. One control participant explained that they had started doing aerobic and 680 
strength training 3-4 times per week during the study. 681 
Seventeen interviewees responded “yes” when asked if the NHS should offer supervised exercise 682 
training to people with Crohn’s disease. A further four interviewees responded “no”, but suggested 683 
that advice and education on exercise should be provided to patients. There was no consensus 684 
amongst participants about how much they would be willing to spend on exercise if supervised 685 
exercise was promoted but not freely available (range £3-30 per session and £10-100 per month). 686 
  687 
  688 
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Additional File 2 - Summary of recruitment survey data 689 
Five researchers from across the three trial sites completed the survey of barriers and facilitators to 690 
recruitment. Two of the five researchers were site principal investigators, two were research nurses, 691 
and the other was a clinical trials assistant. The survey assessed recruitment experiences across six 692 
categories of factors: (i) trial, (ii) site, (iii) patient, (iv) clinical team, (v) information and consent and 693 
(vi) study team.  694 
 695 
Factors that were generally rated as facilitators: 696 
(i) Trial – publicity by the trial team; external publicity; trial management 697 
(ii) Site – choice of recruitment setting; local research culture  698 
(iii) Patient – patients’ attitudes towards exercise interventions 699 
(iv) Clinical team – research experience of the team; motivation of clinical team; perceived 700 
importance of the particular research question; communication skills of clinical team; clinician 701 
attitude to involving patients in research  702 
(v) Information and consent – clarity in presentation of trial information; time and setting of 703 
consent seeking; senior doctors and nurses seeking consent; experience and training of clinical team 704 
seeking consent 705 
(vi) Study team – motivation of the study team at site; communication and coordination 706 
between study team members at site; communication and coordination between study team at site 707 
and the external trial management team; research experience of PI and study team members at site 708 
 709 
Factors that were generally rated as barriers: 710 
(i) Trial – none  711 
(ii) Site – none  712 
(iii) Patient - duration of trial and follow up; additional travel and extra costs 713 
(iv) Clinical team – clinical workload; difficulty in approaching patients for consent 714 
(v) Information and consent – none  715 
(vi) Study team – none 716 
 717 
Various strategies were implemented during the trial to try and enhance recruitment, which had 718 
varying success. Strategies included (i) providing potentially-eligible patients with stool samples pots 719 
ahead of their clinic visit so that they could bring a stool sample to the clinic and not have to make 720 
an additional visit (subjective assessment - useful); (ii) re-screening of patients that had failed initial 721 
screening due to raised FCP over study limit (useful); (iii) research nurses attending clinics and 722 
actively recruiting patients (useful); (iv) reminders to all clinicians at the beginning of clinics to 723 
consider patients for the trial (partly successful/useful); (v) posters in the waiting room about clinical 724 
research in IBD (useful); posting out invitation letters and information sheets to potentially-eligible 725 
patients on a local database (practical and theoretically useful, but only a couple of people 726 
responded via this method); (vi) regular team meetings (useful). 727 
Ideas were offered about how the trial could have been organised differently to improve 728 
recruitment: (i) having a greater choice of sites for where the exercise is completed, including the 729 
recruiting sites (hospitals); (ii) having more recruiting sites; (iii) having more trial advertisements via 730 
online patient groups and charities; (iv) having a dedicated research assistant to identify and send 731 
out information sheets to all potential subjects. 732 
  733 
  734 
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Additional File 3. Implications and proposed changes for the full-scale trial 
Methodological issue Key findings or issues Implications and proposed changes for the full-scale 
trial 
Study set-up There were no major problems in obtaining NHS 
Ethics or Research Management approvals; 
however slow processes in the Human 
Resources Department at the  University of East 
London meant that we were delayed in being 
able to recruit a research assistant by about 4 
months 
Implication – Trial Management team to engage with HR 
departments about trial staff appointments as soon as 
possible during study set-up 
Eligibility The most common reason for exclusion was 
having active disease; site pre-screening forms 
were incomplete so rates of screening and 
eligibility could not be determined 
Implication – include more robust processes and training for 
the collection of pre-screening data  
Proposed change – remove autoimmune disease as an 
exclusion criterion because in hindsight this was 
unnecessary  
Recruitment  By recruiting 36 participants, we achieved our 
minimum recruitment target (n≥24) but not our 
ideal target (n=45); some sites recruited better 
than others; most participants were recruited via 
face-to-face approach in clinic or advertisements 
posted by Crohn’s and Colitis UK 
Implications – continue to use multiple recruitment strategies; 
include an internal pilot phase to provide ongoing monitoring 
of recruitment issues; only include sites that have a research 
nurse available to support recruitment 
Proposed changes – extend the recruitment period and 
include more sites to accommodate the greater sample size 
Randomisation 
procedures  
The randomisation process worked well Implication – include an internal pilot phase to provide 
ongoing monitoring of the randomisation procedures   
Blinding of participants Participants were not blinded to group allocation 
during follow-up  
Potential change – use a control group that matches the 
exercise programme for attention (e.g., flexibility training) 
Blinding of outcome 
assessors 
Assessors of the anthropometric, 
cardiorespiratory fitness and disease activity 
outcome measures were successfully blinded to 
group allocation 
Implication – costing of the full-scale trial should permit 
funding of blinded outcome assessment at all trial sites  
Other aspects of outcome 
assessment 
We used self-reported rather than objective 
measures of physical activity; we did not use 
endoscopies to directly visualise the effect of 
exercise on the gastrointestinal tract 
Proposed changes – use tri-axial accelerometers to 
objectively measure physical activity; include endoscopic 
evaluation of Crohn’s disease activity 
Potential additional change – include monetary incentives 
and recorded delivery to optimise questionnaire response 
rates  
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Adherence with the 
intervention 
The overall attendance rate was good, but this 
could have been better as some participants 
struggled to fit their sessions around other 
commitments (e.g., work) 
Implication – continue to offer flexibility with the timing of 
sessions; prioritise setting up sites that have training venues 
with good accessibility 
Proposed change – include secondary analyses exploring 
the impact of non- and partial adherence on estimates of 
efficacy  
Potential additional change – collaborate with an 
organisation that manages community-based exercise 
facilities where the intervention could be delivered 7 days per 
week   
Acceptability of the 
intervention to 
participants 
Interview feedback about the exercise 
programmes was generally positive; most 
participants (74%) had a pre-randomisation 
preference for high-intensity interval training 
(HIIT), although two participants were concerned 
that HIIT would be too hard; some participants 
would have liked greater variety in their training 
programme 
Implications – reconsider how the exercise programme is 
presented to potential participants during the recruitment 
process (i.e. try and allay any concerns about difficulty); use 
an intervention that has more variety (see next row) 
Other aspects of the 
intervention  
We did not include muscle and bone 
strengthening and balance activities in the 
exercise programmes; testing two exercise 
programmes in a 3-arm trial will require many 
more participants than testing one programme in 
a 2-arm trial 
Proposed changes – test a single exercise programme that 
includes a combination of aerobic, resistance, balance and 
flexibility exercises 
Potential additional change – include a back-up option of 
home-based training if a participant is unable to attend a 
supervised session 
Retention No participants withdrew from the study and 
outcome completion rates were good (89-97%) 
Implication – include an internal pilot phase to provide 
ongoing monitoring of retention issues 
Logistics of multi-centre 
procedures 
The multicentre procedures worked as planned, 
with good communication maintained between (i) 
the university and hospital pairings and (ii) the 
Trial Management Group and all sites 
Proposed change – as the full-scale trial will involve many 
more sites, we propose that it would be necessary to 
collaborate with a Clinical Trials Unit, which would be 
responsible for coordinating the trial 
Potential change – as eluded above, we may pursue 
delivering the intervention via a community exercise provider 
rather than in university exercise science facilities 
 
 
